Skip to main content

Table 1 Correlation between MRVI1-AS1 expression and the clinicopathologic characteristics of hepatocellular carcinoma

From: Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA

Characteristics

n = 72

MRVI1-AS1 expression

P

Low (n = 36)

High (n = 36)

Age (year)

<50

23

10

13

0.448

≥50

49

26

23

Gender

Male

61

30

31

0.743

Female

11

6

5

HBV infection

Absent

13

8

5

0.358

Present

59

28

31

Serum AFP level (ng/mL)

<20

17

11

6

0.165

≥20

55

25

30

Tumor size (cm)

<5

33

21

12

0.033*

≥5

39

15

24

Number of tumor nodules

1

60

33

27

0.058

≥2

12

3

9

Cirrhosis

Absent

19

12

7

0.181

Present

53

24

29

Venous infiltration

Absent

52

30

22

0.035*

Present

20

6

14

Edmondson–Steiner grading

I + II

47

26

21

0.216

III + IV

25

10

15

TNM stage

I + II

54

32

22

0.007*

III + IV

18

4

14

  1. HBV Hepatitis B virus, AFP Alpha-fetoprotein, TNM Tumor-node-metastasis
  2. *P < 0.05